All News about Gsk Plc ADR
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
(GSK) - Analyzing GSK's Short Interest
October 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/10/09/gsk_building.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/10/06/golf.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/10/06/hln.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Price Over Earnings Overview: GSK
September 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
How Is The Market Feeling About GSK?
September 19, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/10/02/screenshot_2023-10-02_at_6.16.49_pm.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/smart-money.png)
![](https://g.foolcdn.com/editorial/images/749309/gettyimages-1316445673.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/27/joe_biden-photo_via_rawpixel.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/26/screenshot_2023-09-26_at_6.11.54_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/25/scyx.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/25/pfizer.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/19/amazon_prime_rewards_card_32861518627.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/19/gsk.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/18/incy.png?width=1200&height=800&fit=crop)
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
September 18, 2023
Via Benzinga
Exposures
Product Safety
![](https://www.investors.com/wp-content/uploads/2018/09/stock-Incyte-01-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/18/screenshot_2023-09-18_at_6.12.00_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/09/18/gsk_1.png?width=1200&height=800&fit=crop)
Pleasant Surprise For GSK: FDA Approves Bone Marrow Cancer Therapy Acquired Via Sierra Oncology Deal
September 18, 2023
Via Benzinga
Exposures
Product Safety
![](https://mms.businesswire.com/media/20230915284606/en/1891420/5/GSK_Logo_Full_Colour_RGB.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/14/moderna_covid-19_vaccine_2021_g.jpg?width=1200&height=800&fit=crop)
Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs
September 14, 2023
Via Benzinga
Exposures
COVID-19
![](https://investorplace.com/wp-content/uploads/2020/09/mrna-stock-1.jpg)
![](https://www.investors.com/wp-content/uploads/2020/12/Stock-moderna-04-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/12/pill-_image_by_arek_socha_from_pixabay_.jpg?width=1200&height=800&fit=crop)
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
September 12, 2023
Via Benzinga
Exposures
Product Safety
![](https://g.foolcdn.com/editorial/images/746850/healthcare-lab-treatment-research-scientist-1.jpg)
![](https://mms.businesswire.com/media/20230901805289/en/1880497/22/7046681_006_SidelineRSV_SocialCard_fa1.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.